Table of Contents Executive Summary 1 Industry Overview of Parkinson's Disease Drug 1.1 Definition of Parkinson's Disease Drug 1.2 Parkinson's Disease Drug Segment by Type 1.2.1 Global Parkinson's Disease Drug Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Sinemet-CR 1.2.3 Trastal 1.2.4 Madopar 1.2.5 COMT Inhibitor 1.2.6 Other 1.3 Parkinson's Disease Drug Segment by Applications 1.3.1 Global Parkinson's Disease Drug Consumption Comparison by Applications (2014-2025) 1.3.2 Under 40 Years Old 1.3.3 40-65 Years Old 1.3.4 Above 65 Years Old 1.4 Global Parkinson's Disease Drug Overall Market 1.4.1 Global Parkinson's Disease Drug Revenue (2014-2025) 1.4.2 Global Parkinson's Disease Drug Production (2014-2025) 1.4.3 North America Parkinson's Disease Drug Status and Prospect (2014-2025) 1.4.4 Europe Parkinson's Disease Drug Status and Prospect (2014-2025) 1.4.5 China Parkinson's Disease Drug Status and Prospect (2014-2025) 1.4.6 Japan Parkinson's Disease Drug Status and Prospect (2014-2025) 1.4.7 Southeast Asia Parkinson's Disease Drug Status and Prospect (2014-2025) 1.4.8 India Parkinson's Disease Drug Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Parkinson's Disease Drug 2.3 Manufacturing Process Analysis of Parkinson's Disease Drug 2.4 Industry Chain Structure of Parkinson's Disease Drug 3 Development and Manufacturing Plants Analysis of Parkinson's Disease Drug 3.1 Capacity and Commercial Production Date 3.2 Global Parkinson's Disease Drug Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Parkinson's Disease Drug 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Parkinson's Disease Drug Production and Capacity Analysis 4.2 Parkinson's Disease Drug Revenue Analysis 4.3 Parkinson's Disease Drug Price Analysis 4.4 Market Concentration Degree 5 Parkinson's Disease Drug Regional Market Analysis 5.1 Parkinson's Disease Drug Production by Regions 5.1.1 Global Parkinson's Disease Drug Production by Regions 5.1.2 Global Parkinson's Disease Drug Revenue by Regions 5.2 Parkinson's Disease Drug Consumption by Regions 5.3 North America Parkinson's Disease Drug Market Analysis 5.3.1 North America Parkinson's Disease Drug Production 5.3.2 North America Parkinson's Disease Drug Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Parkinson's Disease Drug Import and Export 5.4 Europe Parkinson's Disease Drug Market Analysis 5.4.1 Europe Parkinson's Disease Drug Production 5.4.2 Europe Parkinson's Disease Drug Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Parkinson's Disease Drug Import and Export 5.5 China Parkinson's Disease Drug Market Analysis 5.5.1 China Parkinson's Disease Drug Production 5.5.2 China Parkinson's Disease Drug Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Parkinson's Disease Drug Import and Export 5.6 Japan Parkinson's Disease Drug Market Analysis 5.6.1 Japan Parkinson's Disease Drug Production 5.6.2 Japan Parkinson's Disease Drug Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Parkinson's Disease Drug Import and Export 5.7 Southeast Asia Parkinson's Disease Drug Market Analysis 5.7.1 Southeast Asia Parkinson's Disease Drug Production 5.7.2 Southeast Asia Parkinson's Disease Drug Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Parkinson's Disease Drug Import and Export 5.8 India Parkinson's Disease Drug Market Analysis 5.8.1 India Parkinson's Disease Drug Production 5.8.2 India Parkinson's Disease Drug Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Parkinson's Disease Drug Import and Export 6 Parkinson's Disease Drug Segment Market Analysis (by Type) 6.1 Global Parkinson's Disease Drug Production by Type 6.2 Global Parkinson's Disease Drug Revenue by Type 6.3 Parkinson's Disease Drug Price by Type 7 Parkinson's Disease Drug Segment Market Analysis (by Application) 7.1 Global Parkinson's Disease Drug Consumption by Application 7.2 Global Parkinson's Disease Drug Consumption Market Share by Application (2014-2019) 8 Parkinson's Disease Drug Major Manufacturers Analysis 8.1 Merck 8.1.1 Merck Parkinson's Disease Drug Production Sites and Area Served 8.1.2 Merck Product Introduction, Application and Specification 8.1.3 Merck Parkinson's Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Akorn 8.2.1 Akorn Parkinson's Disease Drug Production Sites and Area Served 8.2.2 Akorn Product Introduction, Application and Specification 8.2.3 Akorn Parkinson's Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 GSK 8.3.1 GSK Parkinson's Disease Drug Production Sites and Area Served 8.3.2 GSK Product Introduction, Application and Specification 8.3.3 GSK Parkinson's Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Novartis 8.4.1 Novartis Parkinson's Disease Drug Production Sites and Area Served 8.4.2 Novartis Product Introduction, Application and Specification 8.4.3 Novartis Parkinson's Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Boehringer Ingelheim 8.5.1 Boehringer Ingelheim Parkinson's Disease Drug Production Sites and Area Served 8.5.2 Boehringer Ingelheim Product Introduction, Application and Specification 8.5.3 Boehringer Ingelheim Parkinson's Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Teva Pharmaceutical 8.6.1 Teva Pharmaceutical Parkinson's Disease Drug Production Sites and Area Served 8.6.2 Teva Pharmaceutical Product Introduction, Application and Specification 8.6.3 Teva Pharmaceutical Parkinson's Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Abbvie 8.7.1 Abbvie Parkinson's Disease Drug Production Sites and Area Served 8.7.2 Abbvie Product Introduction, Application and Specification 8.7.3 Abbvie Parkinson's Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Kyowa Hakko Kirin Pharma 8.8.1 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Sites and Area Served 8.8.2 Kyowa Hakko Kirin Pharma Product Introduction, Application and Specification 8.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 Astellas Pharma 8.9.1 Astellas Pharma Parkinson's Disease Drug Production Sites and Area Served 8.9.2 Astellas Pharma Product Introduction, Application and Specification 8.9.3 Astellas Pharma Parkinson's Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 8.10 Desitin Arzneimittel 8.10.1 Desitin Arzneimittel Parkinson's Disease Drug Production Sites and Area Served 8.10.2 Desitin Arzneimittel Product Introduction, Application and Specification 8.10.3 Desitin Arzneimittel Parkinson's Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.10.4 Main Business and Markets Served 8.11 Endo Pharmaceuticals 8.12 F.Hoffmann-La Roche 8.13 H.Lundbeck 8.14 Valeant 8.15 Apokyn 8.16 Orion 8.17 Stada Arzneimittel 8.18 US WorldMeds 8.19 Valeant Pharmaceuticals 9 Development Trend of Analysis of Parkinson's Disease Drug Market 9.1 Global Parkinson's Disease Drug Market Trend Analysis 9.1.1 Global Parkinson's Disease Drug Market Size (Volume and Value) Forecast 2019-2025 9.2 Parkinson's Disease Drug Regional Market Trend 9.2.1 North America Parkinson's Disease Drug Forecast 2019-2025 9.2.2 Europe Parkinson's Disease Drug Forecast 2019-2025 9.2.3 China Parkinson's Disease Drug Forecast 2019-2025 9.2.4 Japan Parkinson's Disease Drug Forecast 2019-2025 9.2.5 Southeast Asia Parkinson's Disease Drug Forecast 2019-2025 9.2.6 India Parkinson's Disease Drug Forecast 2019-2025 9.3 Parkinson's Disease Drug Market Trend (Product Type) 9.4 Parkinson's Disease Drug Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Parkinson's Disease Drug Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Parkinson's Disease Drug Table Global Parkinson's Disease Drug Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global Parkinson's Disease Drug Production Market Share by Types in 2018 Figure Sinemet-CR Product Picture Figure Trastal Product Picture Figure Madopar Product Picture Figure COMT Inhibitor Product Picture Figure Other Product Picture Table Global Parkinson's Disease Drug Consumption (K Units) Comparison by Applications (2014-2025) Figure Global Parkinson's Disease Drug Consumption Market Share by Applications in 2018 Figure Under 40 Years Old Figure 40-65 Years Old Figure Above 65 Years Old Figure Global Parkinson's Disease Drug Revenue (Million USD) (2014-2025) Figure Global Parkinson's Disease Drug Production (K Units) (2014-2025) Figure North America Parkinson's Disease Drug Market Size (Million USD) (2014-2025) Figure Europe Parkinson's Disease Drug Market Size (Million USD) (2014-2025) Figure China Parkinson's Disease Drug Market Size (Million USD) (2014-2025) Figure Japan Parkinson's Disease Drug Market Size (Million USD) (2014-2025) Figure Southeast Asia Parkinson's Disease Drug Market Size (Million USD) (2014-2025) Figure India Parkinson's Disease Drug Market Size (Million USD) (2014-2025) Table Parkinson's Disease Drug Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Parkinson's Disease Drug in 2018 Figure Manufacturing Process Analysis of Parkinson's Disease Drug Figure Industry Chain Structure of Parkinson's Disease Drug Table Capacity and Commercial Production Date of Key Manufacturers Table Global Parkinson's Disease Drug Manufacturing Plants Distribution Table Parkinson's Disease Drug Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Parkinson's Disease Drug Capacity (K Units) of Major Manufacturers (2014-2019) Table Parkinson's Disease Drug Production (K Units) of Major Manufacturers (2014-2019) Table Parkinson's Disease Drug Production Market Share of Major Manufacturers (2014-2019) Figure Parkinson's Disease Drug Production Share by Manufacturers in 2018 Table Parkinson's Disease Drug Revenue (Million US$) of Major Manufacturers (2014-2019) Table Parkinson's Disease Drug Revenue Market Share of Major Manufacturers (2014-2019) Figure Parkinson's Disease Drug Revenue Share by Manufacturers in 2018 Table Parkinson's Disease Drug Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Parkinson's Disease Drug Production by Regions 2014-2019 (K Units) Table Global Parkinson's Disease Drug Production Market Share by Regions 2014-2019 Figure Global Parkinson's Disease Drug Production Market Share by Regions in 2018 Table Global Parkinson's Disease Drug Revenue by Regions 2014-2019 (Million USD) Table Global Parkinson's Disease Drug Revenue Market Share by Regions 2014-2019 Figure Global Parkinson's Disease Drug Revenue Market Share by Regions in 2018 Table Global Parkinson's Disease Drug Consumption by Regions 2014-2019 (K Units) Table Global Parkinson's Disease Drug Consumption Market Share by Regions 2014-2019 Figure North America Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units) Figure North America Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD) Table North America Parkinson's Disease Drug Production, Consumption Import and Export (K Units) Figure Europe Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units) Figure Europe Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD) Table Europe Parkinson's Disease Drug Production, Consumption Import and Export (K Units) Figure China Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units) Figure China Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD) Table China Parkinson's Disease Drug Production, Consumption Import and Export (K Units) Figure Japan Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units) Figure Japan Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD) Table Japan Parkinson's Disease Drug Production, Consumption Import and Export (K Units) Figure Southeast Asia Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Parkinson's Disease Drug Production, Consumption Import and Export (K Units) Figure India Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units) Figure India Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD) Table India Parkinson's Disease Drug Production, Consumption Import and Export (K Units) Figure Global Consumption Parkinson's Disease Drug Market Share by Application (2014-2019) Figure Global Value (Consumption) Parkinson's Disease Drug Market Share by Application (2014-2019) Table Merck Parkinson's Disease Drug Production Sites and Area Served Table Merck Parkinson's Disease Drug Product Introduction, Application and Specification Table Merck Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Merck Parkinson's Disease Drug Production Growth Rate (2014-2019) Table Merck Parkinson's Disease Drug Production Market Share (2014-2019) Figure Merck Parkinson's Disease Drug Revenue Market Share (2014-2019) Table Merck Parkinson's Disease Drug Main Business and Markets Served Table Akorn Parkinson's Disease Drug Production Sites and Area Served Table Akorn Parkinson's Disease Drug Product Introduction, Application and Specification Table Akorn Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Akorn Parkinson's Disease Drug Production Growth Rate (2014-2019) Table Akorn Parkinson's Disease Drug Production Market Share (2014-2019) Figure Akorn Parkinson's Disease Drug Revenue Market Share (2014-2019) Table Akorn Parkinson's Disease Drug Main Business and Markets Served Table GSK Parkinson's Disease Drug Production Sites and Area Served Table GSK Parkinson's Disease Drug Product Introduction, Application and Specification Table GSK Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table GSK Parkinson's Disease Drug Production Growth Rate (2014-2019) Table GSK Parkinson's Disease Drug Production Market Share (2014-2019) Figure GSK Parkinson's Disease Drug Revenue Market Share (2014-2019) Table GSK Parkinson's Disease Drug Main Business and Markets Served Table Novartis Parkinson's Disease Drug Production Sites and Area Served Table Novartis Parkinson's Disease Drug Product Introduction, Application and Specification Table Novartis Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Parkinson's Disease Drug Production Growth Rate (2014-2019) Table Novartis Parkinson's Disease Drug Production Market Share (2014-2019) Figure Novartis Parkinson's Disease Drug Revenue Market Share (2014-2019) Table Novartis Parkinson's Disease Drug Main Business and Markets Served Table Boehringer Ingelheim Parkinson's Disease Drug Production Sites and Area Served Table Boehringer Ingelheim Parkinson's Disease Drug Product Introduction, Application and Specification Table Boehringer Ingelheim Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Boehringer Ingelheim Parkinson's Disease Drug Production Growth Rate (2014-2019) Table Boehringer Ingelheim Parkinson's Disease Drug Production Market Share (2014-2019) Figure Boehringer Ingelheim Parkinson's Disease Drug Revenue Market Share (2014-2019) Table Boehringer Ingelheim Parkinson's Disease Drug Main Business and Markets Served Table Teva Pharmaceutical Parkinson's Disease Drug Production Sites and Area Served Table Teva Pharmaceutical Parkinson's Disease Drug Product Introduction, Application and Specification Table Teva Pharmaceutical Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Teva Pharmaceutical Parkinson's Disease Drug Production Growth Rate (2014-2019) Table Teva Pharmaceutical Parkinson's Disease Drug Production Market Share (2014-2019) Figure Teva Pharmaceutical Parkinson's Disease Drug Revenue Market Share (2014-2019) Table Teva Pharmaceutical Parkinson's Disease Drug Main Business and Markets Served Table Abbvie Parkinson's Disease Drug Production Sites and Area Served Table Abbvie Parkinson's Disease Drug Product Introduction, Application and Specification Table Abbvie Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Abbvie Parkinson's Disease Drug Production Growth Rate (2014-2019) Table Abbvie Parkinson's Disease Drug Production Market Share (2014-2019) Figure Abbvie Parkinson's Disease Drug Revenue Market Share (2014-2019) Table Abbvie Parkinson's Disease Drug Main Business and Markets Served Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Sites and Area Served Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Product Introduction, Application and Specification Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Growth Rate (2014-2019) Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Market Share (2014-2019) Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Revenue Market Share (2014-2019) Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Main Business and Markets Served Table Astellas Pharma Parkinson's Disease Drug Production Sites and Area Served Table Astellas Pharma Parkinson's Disease Drug Product Introduction, Application and Specification Table Astellas Pharma Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Astellas Pharma Parkinson's Disease Drug Production Growth Rate (2014-2019) Table Astellas Pharma Parkinson's Disease Drug Production Market Share (2014-2019) Figure Astellas Pharma Parkinson's Disease Drug Revenue Market Share (2014-2019) Table Astellas Pharma Parkinson's Disease Drug Main Business and Markets Served Table Desitin Arzneimittel Parkinson's Disease Drug Production Sites and Area Served Table Desitin Arzneimittel Parkinson's Disease Drug Product Introduction, Application and Specification Table Desitin Arzneimittel Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Desitin Arzneimittel Parkinson's Disease Drug Production Growth Rate (2014-2019) Table Desitin Arzneimittel Parkinson's Disease Drug Production Market Share (2014-2019) Figure Desitin Arzneimittel Parkinson's Disease Drug Revenue Market Share (2014-2019) Table Desitin Arzneimittel Parkinson's Disease Drug Main Business and Markets Served Table Endo Pharmaceuticals Parkinson's Disease Drug Production Sites and Area Served Table F.Hoffmann-La Roche Parkinson's Disease Drug Production Sites and Area Served Table H.Lundbeck Parkinson's Disease Drug Production Sites and Area Served Table Valeant Parkinson's Disease Drug Production Sites and Area Served Table Apokyn Parkinson's Disease Drug Production Sites and Area Served Table Orion Parkinson's Disease Drug Production Sites and Area Served Table Stada Arzneimittel Parkinson's Disease Drug Production Sites and Area Served Table US WorldMeds Parkinson's Disease Drug Production Sites and Area Served Table Valeant Pharmaceuticals Parkinson's Disease Drug Production Sites and Area Served Figure Global Parkinson's Disease Drug Production (K Units) Growth Rate Forecast 2019-2025 Figure Global Parkinson's Disease Drug Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Parkinson's Disease Drug Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units) Figure North America Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units) Figure China Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units) Figure India Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of Parkinson's Disease Drug by Type (2019-2025) Table Global Consumption (K Units) of Parkinson's Disease Drug by Application (2019-2025) Table Parkinson's Disease Drug Distributors List Table Parkinson's Disease Drug Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Merck Akorn GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie Kyowa Hakko Kirin Pharma Astellas Pharma Desitin Arzneimittel Endo Pharmaceuticals F.Hoffmann-La Roche H.Lundbeck Valeant Apokyn Orion Stada Arzneimittel US WorldMeds Valeant Pharmaceuticals